This presentation is the property of its rightful owner.
Sponsored Links
1 / 52

处方点评 - 问题处方分析 PowerPoint PPT Presentation


  • 53 Views
  • Uploaded on
  • Presentation posted in: General

处方点评 - 问题处方分析. 赵志刚 首都医科大学附属北京天坛医院药剂科 [email protected] 总则: 处方管理的一般规定 处方权的获得 处方的开具 处方的调剂 监督管理 法律责任 附则. 修订背景: 2002 年 3 月起草处方管理办法 2004 年 8 月颁布试行 提升为卫生部规范性文件 试行两年对 《 处方管理办法(试行) 》 评价 2006 年初提出修订 2007 年 2 月 12 日公布, 5 月 1 日起实施. 《 处方管理办法 》 宗旨 : 规范处方管理 提高处方质量

Download Presentation

处方点评 - 问题处方分析

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


6116874

-

[email protected]


6116874


6116874

20023

20048

2006

200721251


6116874

  • :


6116874

28


6116874


6116874


6116874


6116874

;

;

;


6116874

  • 18


6116874

1

222

3


6116874

4

5

6


6116874

7

8

9

10


6116874

11

12

13


6116874

14

15

16


6116874

17

18


6116874

.


6116874


6116874

12


6116874

1 23

  • / [0.375*6] 0.375/Bid

  • 20 2/tid

  • 150ml 10ml/tid

    6


6116874

1.

2./

3./45MIC q8h


6116874

4.////3

5.

6.


6116874

2

  • [0.1*12] 0.4 qd

  • [20g*4] 20g tid

  • [0.3mg*20] 0.3mg tid

  • [50mg*100] 100mg tid

    4


6116874

1 0.2g 2 0.4g

2 2

350%

4 1


6116874

3 40

  • 1 5mg*10 5mg qd

  • [50ml/12.5g*4] 25g qod

  • 3000U*3 3000U 3/

    5


6116874

g/ml

5%0.9%10%

Hgb12g/L


6116874

4 70

  • [0.35g*6] 0.35g Bid 24

  • [75mg*10] 75mg Bid 30

  • [0.24*42] 0.48g tid 42


6116874

1

1 20mg Bid H2 20mg Bid

0.5g tid + 0.5g qid

0.3qid 50mg tid 68


6116874

2COX22

75mg150mg


5 40 dm

5 40DM

  • [5ml/25mg] 2 q2h

  • [0.1% 10ml] 2 q8h

    5


6116874

120min 1224h1

2 0.5g tid

DM2TDM2

121


6116874

6

  • [2.5mg*80] 10mg qd 80

  • [40mg*7] 40mg qd 28

  • [50mg*100] 100mg qd 100

    3

    INR23


6116874

1. P450 CYP2C9CYP2C9CYP2C92,

2.2.5-5mg.

3


6116874

7: 20

  • 0.2

  • 0.9 100ml bid ivgtt 5

  • 1.8

  • 5GS 500ml qd ivgtt 5

    5


6116874

1,ADR

2301125


6116874

3N-M

40.6~1.2(2-4)

5500ml


6116874

8 : 10Y

10% 500mLx2

640u 320u ,qd

625mg8 po,625mgbid

300mg2po,150mgbid


6116874

1.MICMIC40~50%MIC;

2.:


6116874

3.10 d

4.,

5.:12


6116874

9 17Y

5% 5%100mL 1100mL qd

2mL0.1gx 4400mg qd

0.25g 6 500mg po qd

18 2# po tid

4mg3 4mg po


6116874

1.;

2.2;

3.12.5mg7mg25mg2mg

4.18

5.


6116874

10 35Y

500mgx10 500mg

10mgx20 20mg po tid

75ugx20 75ug po qd

20mgx30 20mg po qd


6116874

1.

2.ACEIARB,

3.510mg12 1020mg40mg

4.6875ug po bid-qid

5.


6116874

11 75Y,

50mgx20 50mg po bid

250mgx6 250mg bid

10% 500mlx6 500ml bid

15mgx5 15mg ,tid


6116874

1.A, A,

2.0.2g12240.1g650mg

3.10 d


6116874

4.0.51.0g2310ml0.5g20ml1g,5%5%100ml4%1ml

5.


6116874

12 80Y,

250mgx12 500mg bid

5% 100mlx6 100ml bid

1gx6 2g ,tid

100mlX6 200ml tid


6116874

1.,:0.5g/d,1/d,2,,0.5g/d,7-10

2.:0.1g/ml,250-500ml0.9%N5%,60min.2.0mg/ml

3.:


6116874

4.12g/d24g/d

5.:1g10ml100ml


  • Login